The new TNM classification and micrometastases
Related Experiment Video
Updated: Aug 29, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
1Division of Cancer Sciences and Molecular Pathology, Section of Gene Regulation and Mechanisms of Disease, Department of Pathology, University of Glasgow, Western Infirmary, Glasgow, Scotland, UK.
Abstract:
The 6th Edition of the TNM classification is considered with particular reference to the evidence base for the analysis of lymph nodes. The justification for the definition of a micrometastasis is considered and in particular the problems related to describing a node deposit of less than 200 microm as NO. Such a classification in the absence of clear instructions on node examination is of limited value in terms of comparing different centres and even within the same centre. The classification does not embrace the rapid advances in the biology of breast cancer and some of these are considered as possible ways forward. TNM is meant to be pragmatic and evidence based leading to indications for treatment and a uniform approach between centres. In the former it succeeds, but some of the definitions would appear to be based on limited established data.
Related Concept Videos
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

